AmeriCann (OTCQX: ACAN), developer of the proposed Massachusetts Medical Cannabis Center (MMCC) cultivation and processing facility, today unveiled its latest line of nutraceutical-grade cannabis-infused products. AmeriCann will license the intellectual property behind “Solanna” to regulated cannabis businesses looking to offer healthier alternatives to smoking, including capsules, topical lotions and balms, sublingual tinctures, oral dissolving film, trans-dermal applications, and oil cartridges for vaporizing. The company says it intends to later expand the product line to include edible products, health drinks, and branded concentrates offered at varying dosages.
To view the full press release, visit: http://nnw.fm/lUwH6
About AmeriCann, Inc.
AmeriCann is a publicly traded company that designs and plans to develop and lease sustainable, state-of-the-art medical cannabis cultivation properties. The Company has over 1,000,000 square feet of facilities in the planning and design stages of development. AmeriCann has preferred partners in Colorado and Massachusetts. The preferred partner in Colorado commenced operations in 2014 but as of the date of this report, the Preferred Partner in Massachusetts is not yet operating. AmeriCann does not currently cultivate, process or distribute cannabis, but partners with local businesses to serve marijuana patients in their communities. AmeriCann, Inc. is a Certified B Corp, an acknowledgment of the company’s commitment to social and environmental ethics, transparency and accountability. AmeriCann became the first public cannabis company to earn this respected accreditation. More information about the Company is available at: www.americann.co.
NetworkNewsBreak is a rapid summary of a press release that caught the attention of CannabisNewsWire (CNW). CNW provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, CNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing network of more than 5,000 key distribution outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. For more information, visit https://www.CannabisNewsWire.com.
Please see full disclaimers on the CannabisNewsWire website: http://nnw.fm/Disclaimer